Velocity Clinical Research strengthens management team amid European expansion
DURHAM, NC., Aug. 12, 2021 /PRNewswire/ -- The world's largest integrated clinical trial site organisation, Velocity Clinical Research ("Velocity"), today announces it has strengthened its management team as it embarks on European expansion.
- DURHAM, NC., Aug. 12, 2021 /PRNewswire/ -- The world's largest integrated clinical trial site organisation, Velocity Clinical Research ("Velocity"), today announces it has strengthened its management team as it embarks on European expansion.
- Dr G. Paul Evans, Chief Executive and President of Velocity Clinical Research, said, "Velocity is carving out a new category of pharma services.
- The clinical trials site landscape will look very different in the next 12 months and Velocity is well placed to take advantage of this consolidation in the market.
- Dominic Clavell joins Velocity to head up its European operations after a decorated career in some of the top clinical research organisations, site management organisations and pharmaceutical companies in the world, such as Parexel, IQVIA, Synexus and Novartis.